TMCnet News
Global Neurovascular Devices Market to Surpass US$ 3,180.7 Million by 2027, Says Coherent Market Insights (CMI)According to Coherent Market Insights, the global neurovascular devices market is estimated to be valued at US$ 2,340.4 million in 2020 and is expected to exhibit a CAGR of 4.1% during the forecast period (2020-2027). Key Trends and Analysis of the Global Neurovascular Devices Market: The global neurovascular devices market is expected to witness significant growth, owing to increasing regulatory approvals of device. For instance, on August 3, 2020, Stryker Corporation announced that it received the U.S. FDA approval for an expanded indication of its Neuroform Atlas Stent System, becoming the first and only adjunctive stent approved for use in posterior (back of the brain) circulation. Moreover, in February 2020, Cerus Endovascular Ltd. received European CE Mark approval for its lead product, the Contour Neurovascular System, for the treatment of intracranial aneurysms. Launches of neurovascular devices is also expected to drive growth of the global neurovascular devices market. For instance, in August 2020, Stryker Corporation announced the launch of the Surpass Evolve Flow Diverter following approval from the U.S. Food and Drug Administration. It is the first 64-wire cobalt chromium flow diverter in the U.S. designed to re-direct blood flow and promote aneurysm healing. Furthermore, in July 2016, Penumbra, Inc. launched ACE 68 Reperfusion Catheter for the treatment of acute ischemic stroke. Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4224 Key Market Takeaways: The global neurovascular devices market is expected to exhibit a CAGR of 4.1 % during the forecast period (2020-2027), owing to the increasing technological advancements in microgudewires. For instance, in September 2019, the engineers at Massachusetts Institute o Technology, U.S. developed a robotic thread (in black color) that can be steered magnetically and is small enough to work through narrow spaces such as the vasculature of the human brain for treatment of blood vessel blockage in the brain. North America is expected to be the most lucrative region in the neurovascular devices market due to the increasing prevalence of stroke in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), stroke resulted in death of about 140,000 Americans, which was 1 out of every 20 deaths, in 2018. Competitive Landscape: Key players operating in the global neurovascular devices market include Medtronic Plc., Abbott Laboratories, Johnson & Johnson, Merit Medical Systems, Inc., Stryker Corporation, Penumbra, Inc., Acandis GmbH & Co. KG, MicroPort Scientific Corporation, Terumo Corporation, and Cerus Endovascular Limited. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4224 Market Segmentation:
Related Market Intelligence Report: Implant & Prosthesis Fastener Market, By Type (Stainless Steel, Titanium, Bioabsorbable, and Others), By Application (Dental, Spinal, Orthopedic, and Facial), By End User (Hospitals, Clinics, and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027 Read more: https://www.coherentmarketinsights.com/market-insight/implant-and-prosthesis-fastener-market-4200 About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201009005130/en/ |
